Bausch Health Companies | Lucro Operacional



Operating Profit Alterar Data
Amgen USD 2.31B 182M 2024-12
ANI Pharmaceuticals USD -4378000 16.14M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bausch Health Companies USD 318M 105M 2024-09
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Danaher USD 1.42B 467M 2024-12
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Pacira USD 24.7M 164.23M 2024-12
Perrigo USD 112.7M 37.4M 2024-12
Prestige Brands USD 91.96M 7.62M 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Zoetis USD 732M 142M 2024-12



Bausch Health Companies Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.